Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Brightspire Capital Inc
(NY:
BRSP
)
5.680
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Brightspire Capital Inc
< Previous
1
2
Next >
BRSP Stock Earnings: BrightSpire Capital Meets EPS, Beats Revenue for Q2 2024
July 30, 2024
BRSP stock results show that BrightSpire Capital met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
BRSP Stock Earnings: BrightSpire Capital Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
BRSP stock results show that BrightSpire Capital beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
GameStop Posts Downbeat Results, Joins Direct Digital, Forge Global And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 27, 2024
U.S. stock futures were higher this morning, with the Dow futures gaining by more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Downgrades Flood In For Commercial Real Estate Stocks: Analysts Warn Of 'Rocky Road Ahead'
March 04, 2024
Bank of America has downgraded six Commercial Real Estate mortgage REITs. Here's why.
Via
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
Earnings Preview For BrightSpire Capital
February 20, 2024
Via
Benzinga
Earnings Outlook For BrightSpire Capital
October 27, 2023
Via
Benzinga
Looking Into BrightSpire Capital's Return On Capital Employed
May 09, 2023
Via
Benzinga
BrightSpire Capital: Q1 Earnings Insights
May 03, 2023
Via
Benzinga
Looking Into BrightSpire Capital's Return On Capital Employed
February 22, 2023
Via
Benzinga
US Mortgage Applications Surge As Rates Dip: Is The Industry Moving Out Of The Woods? Plus: Stocks, ETFs To Watch
November 22, 2023
The latest data from the Mortgage Bankers Association (MBA) revealed a significant uptick in U.S. mortgage applications.
Via
Benzinga
Topics
ETFs
These 3 REITs Just Jumped Higher On Earnings Beats
November 02, 2023
Via
Benzinga
The Best-Performing Mortgage REITs In 2023
March 03, 2023
Among real estate investment trusts (REITs), one of the most popular subsectors with investors are mortgage REITs (mREITs). Although mREITs can be extremely volatile, their dividend yields are usually...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
March 01, 2023
Via
Benzinga
Recap: BrightSpire Capital Q1 Earnings
May 03, 2022
BrightSpire Capital (NYSE:BRSP) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For October 30, 2023
October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
Via
Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...
Via
Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 01, 2023
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via
Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
March 01, 2023
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 01, 2023
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 01, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
A Look Into Real Estate Sector Value Stocks
January 16, 2023
Via
Benzinga
These 3 Mortgage REITs Have Yields Of Over 13% And Are Trading For Far Less Than They're Worth
November 19, 2022
The VanEck Mortgage REIT Income ETF (ARCA: MORT) is down roughly 31% year-to-date, as a series of interest rate hikes by the Federal Reserve has sent a shock through real estate-related industries....
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
Via
Benzinga
BrightSpire Capital: Q3 Earnings Insights
November 02, 2022
BrightSpire Capital (NYSE:BRSP) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings BrightSpire Capital...
Via
Benzinga
BrightSpire Capital: Q2 Earnings Insights
August 03, 2022
BrightSpire Capital (NYSE:BRSP) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
BrightSpire Capital's Return On Capital Employed Insights
February 23, 2022
According to Benzinga Pro, during Q4, BrightSpire Capital (NYSE:BRSP) earned $83.26 million, a 216.15% increase from the preceding quarter. BrightSpire Capital also posted a total...
Via
Benzinga
Recap: BrightSpire Capital Q4 Earnings
February 22, 2022
BrightSpire Capital (NYSE:BRSP) reported its Q4 earnings results on Tuesday, February 22, 2022 at 08:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022
February 18, 2022
Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
December 17, 2021
Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ:
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.